Drug injector device maker SHL Group is investing $40 million this year at its injection molding facilities in Taiwan in response to new product launches by customers in the pharmaceutical sector. SHL ...

ZUG, Switzerland, April 1, 2025 /PRNewswire/ -- SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new ...

TAOYUAN, TAIWAN — For Taiwanese injection molder SHL Group, a niche focus manufacturing devices for a new class of pricey biologically-based drugs has become big business, to the tune of $140 million ...

TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...

Drug-delivery devicemaker SHL is expanding its Taiwan venture by $40 million this year, investing in facilities for its line of auto injectors, pen injectors and inhalers. The company, which sells its ...

ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake ...

ZUG, Switzerland, May 3, 2023 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, ...